Skip to search boxSkip to navigationSkip to main content

A recombinant inhibitory isoform of vascular endothelial growth factor 164/165 aggravates ischemic brain damage in a mouse model of focal cerebral ischemia

  • ,
  • Walter E. Cromer
    ,
  • Courtney P. Parker
    ,
  • Pierre O. Couraud
    ,
  • Ignacio A. Romero
    ,
  • Babette Weksler
*Corresponding author for this work
  • LSU Health Sciences Center - Shreveport
    ,
  • Cardiovascular Research Institute
    ,
  • Université Paris Cité
    ,
  • Open University Milton Keynes
    ,
  • Cornell University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

Vascular endothelial growth factors (VEGF) are a Janus-faced family of growth factors exerting both neuroprotective and maladaptive effects on the blood-brain barrier. For example, VEGFs are beneficial in promoting postischemic brain angiogenesis, but the newly formed vessels are leaky. We investigated the role of the naturally occurring murine inhibitory VEGF isoform VEGF 165b in a mouse model of focal cerebral ischemia by middle cerebral artery occlusion and reperfusion (I/R) in male C57BL/6 mice. We investigated the roles of VEGF164/165 and VEGF165b in both brain and nonbrain endothelial barrier, angiogenesis, and neutrophil migration using oxygen glucose deprivation and reoxygenation as in vitro model. We investigated the role of VEGF165b in brain edema, neutrophil infiltration, ischemic brain damage, and neuronal death in vivo using an adenovirus encoding a recombinant VEGF164b isoform. Neither VEGF164/165 nor VEGF165b significantly altered brain endothelial barrier or angiogenesis in vitro. However, treatment of brain endothelial cells with VEGF165b increased neutrophil migration in vitro and exacerbated stroke injury by aggravating neutrophil infiltration and neurodegeneration in vivo. Our results indicate that alterations in the delicate balance in the relative levels of pro- and antiangiogenic VEGF isoforms can result in either adaptive or detrimental effects, depending on the VEGF isoform levels and on the duration and extent of injury.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1010-1024 (15 pages)

Journal (Volume, Issue Number)

American Journal of Pathology (Volume 183, Issue 3)

Publication milestones

  • Published - 09/2013

Publication status

Published - 09/2013

ISSN

0002-9440

Publication IDs

  • Scopus: 84883175104
  • PubMed: 23906811

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
37
Citation count
18

Funding Details

Supported by a postdoctoral grant from the Malcolm-Feist Cardiovascular Research Endowment–Shreveport (G.V.C.) and by Department of Defense award DOD W W81XWH-10-1-0717 (J.S.A.).
FundersFunding numbers
Malcolm Feist Cardiovascular Research Endowment-LSU Health Sciences Center-Shreveport
-
EC
-
DOD
DOD W W81XWH-10-1-0717
FP7
202213